AIR340B Coalition Commends Senator Cassidy for Investigating 340B Contract Pharmacy Abuses
WASHINGTON – The Alliance for Integrity and Reform of 340B (AIR340B) issued the following statement regarding a request from U.S. […]
340B In The News
AIR340B Weighs in on Bipartisan Senate Request for Information
AIR340B submitted a response to a bipartisan Senate request for information (RFI) on the state of the 340B program — an opportunity
New Report Shows Charity Care at 340B Hospitals is on a Downward Trend
WASHINGTON – Today, the Alliance for Integrity and Reform of 340B (AIR340B) released a report analyzing the latest charity care
AIR 340B Responds to Senators’ Bipartisan 340B Working Group
On behalf of the Alliance for Integrity and Reform of 340B (AIR340B), thank you for the opportunity to share our
What’s in a Name? Rural Referral Centers Capture 340B Discounts Without Serving Rural, Vulnerable Patients
The 340B Drug Pricing Program is intended to help low-income and vulnerable patient populations and the true safety-net providers that
Two-Thirds of 340B DSH Hospitals Are Not Located in Medically Underserved Areas
Analysis Raises Questions on How 340B DSH Hospitals Are Providing Care to Underserved Communities if They Are Not Located in
IQVIA: The 340B Drug Pricing Program Exceeds $100B in 2022
This article is the latest in IQVIA’s series of yearly reports on the size and growth of the 340B drug
The New York Times: How a Hospital Chain Used a Poor Neighborhood to Turn Huge Profits
Bon Secours Mercy Health, a major nonprofit health system, used the poverty of Richmond Community Hospital’s patients to tap into
The Wall Street Journal: Many Hospitals Get Big Drug Discounts. That Doesn’t Mean Markdowns for Patients.
A decades-old federal program that offered big drug discounts to a small number of hospitals to help low-income patients now
30 Years of 340B: Policymakers Must Act Now to Prioritize Transparency, Accountability, and Oversight
With the 340B program marking its 30th anniversary in November, we must ask: who is benefiting from this drug pricing